Ankit G.

Ankit G. has extensive work experience in various roles related to corporate strategy, business finance, and investor relations. Ankit has held positions in companies such as Gland Pharma Limited, GLG, Cenexi, Strides, Biocon, Christensen, Jay Switches India (P) Limited, and Parabolic Drugs. Their responsibilities have included crafting and executing investment strategies, driving post-merger integrations, overseeing strategic alliances and global partnerships, and leading financial planning and analysis. Ankit has also worked on initiatives related to environmental, social, and governance aspects and has experience in the pharma and manufacturing industries.

Ankit G. obtained a Master of Business Administration (MBA) in Accounting and Finance from Kurukshetra University in 2010. In 2016, they received a degree in Corporate Financial Analysis from the University of Michigan. Ankit then pursued a degree in Advanced Valuation and Strategy - M&A, Private Equity, and Venture Capital from Erasmus University Rotterdam from 2018 to 2019. Ankit also attended SDA Bocconi in 2017 for a course in Private Equity and Venture Capital. Ankit further expanded their education in 2019 by completing an Introductory Certificate on Drug Discovery in Medicinal and Pharmaceutical Chemistry from UC San Diego. Additionally, they obtained a Bachelor of Business Administration (BBA) in Business Administration and Management, General from Kurukshetra University in 2008. Ankit also completed a course in Financial Markets from the Yale School of Management in 2017. Ankit has pursued additional certifications in various areas such as corporate finance, sustainable and ESG supply chains, advanced Excel, financial literacy, data analytics, business valuation, and more.